香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 XIAMEN JIHONG CO., LTD 廈門吉宏科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2603） 董事會會議召開日期 廈 門 吉 宏 科 技 股 份 有 限 公 司（「本公司」）董 事 會（「董事會」）宣 佈，將 於2025年8月 20日 舉 行 董 事 會 會 議，藉 以（其 中 包 括）審 議 及 批 准 本 公 司 及 其 附 屬 公 司 截 至 2025年6月30日止六個月的中期業績及其刊發，及其他議題。 承董事會命 廈門吉宏科技股份有限公司 執行董事兼總經理 莊 浩 香港，2025年8月5日 於 本 公 告 日 期，董 事 會 由 董 事 長 兼 執 行 董 事 王 亞 朋 先 生、執 行 董 事 莊 浩 女 士、 張和平先生、莊澍先生及陸它山先生；非執行董事廖生興先生；以及獨立非執行 董事張國清 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 XIAMEN JIHONG CO., LTD 廈門吉宏科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2603） （「本公司」） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而做出。 茲載列廈門吉宏科技股份有限公司於巨潮資訊網(www.cninfo.com.cn)刊登的公告 如下，僅供參閱。 承董事會命 廈門吉宏科技股份有限公司 執行董事兼總經理 莊浩女士 香港，2025年8月5日 关于公司董事长减持股份的预披露公告 公司董事长王亚朋先生保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有公司股份数量 12,179,900 股（占公司目前总股本 452,679,288 股的比例 ...

Group 1 - Tianyue Advanced, the world's second-largest silicon carbide substrate manufacturer, has passed the Hong Kong Stock Exchange hearing, while lithium battery giant XWANDA and AI inference chip service provider Yuntian Lifi have submitted their listing applications [1] - As of July 30, a total of 236 companies are queued for Hong Kong stock listings, with 42 A-share companies having submitted their applications [5][8] - In 2023, 10 companies successfully listed in Hong Kong, raising a total of HKD 88.286 billion, with CATL leading at HKD 41.006 billion, marking the largest IPO globally this year [2][4] Group 2 - The average cumulative increase for the 10 A+H shares listed this year is 38.55%, with notable performers including Jihong Co. at 117.71% and Hengrui Medicine at 79% [4] - The Hong Kong Stock Exchange has seen significant inflows, with over HKD 850 billion entering the market this year, surpassing the total for 2024 [12] - A growing number of A-share companies are choosing to list in Hong Kong due to supportive domestic policies and improved liquidity in the Hong Kong market [12][13]

Core Insights - The article highlights the changes in the Hong Kong Stock Connect holdings, indicating which companies have seen the largest increases and decreases in shareholding percentages. Group 1: Increased Holdings - Changfei Optical Fiber Cable (06869) saw the largest increase in holdings, up by 3.06% to a total holding of 41.69% [1][2] - Kanglong Chemical (03759) increased by 2.36%, reaching a holding of 54.24% [1][2] - Yisou Technology (02550) rose by 1.80%, with a current holding of 58.01% [1][2] - Other notable increases include China Zhongjin (01880) with a 0.78% increase to 41.73% and Shanghai Electric (02727) with a 0.76% increase to 43.36% [2] Group 2: Decreased Holdings - Shandong Xinhua Pharmaceutical (00719) experienced the largest decrease, down by 1.74% to a holding of 46.02% [1][3] - Southern Hengsheng Technology (03033) decreased by 0.95%, now holding 61.82% [1][3] - Jihong Co., Ltd. (02603) saw a reduction of 0.91%, with a current holding of 37.85% [1][3] - Other significant decreases include Junshi Biosciences (01877) down by 0.76% to 50.62% and New China Life Insurance (01336) down by 0.71% to 53.23% [3][4] Group 3: Five-Day Changes - Over the last five trading days, Yisou Technology (02550) had the highest increase of 13.77%, reaching 58.01% [5] - Changfei Optical Fiber Cable (06869) increased by 9.53% to 41.69% [5] - The Hang Seng China Enterprises Index (02828) rose by 5.73%, now at 7.19% [5] - Other notable increases include China Energy Construction (03996) up by 5.39% to 21.41% [5] Group 4: Twenty-Day Changes - In the last twenty days, Haotian International Construction (01341) saw the largest increase of 33.88%, reaching 59.80% [8] - Jihong Co., Ltd. (02603) increased by 26.53% to 37.85% [8] - Yisou Technology (02550) rose by 19.75% to 58.01% [8] - Other significant increases include Oriental Electric (01072) up by 15.27% to 43.05% [8] Group 5: Summary of Trends - The data indicates a trend of increasing foreign investment in certain technology and pharmaceutical companies, while traditional sectors like pharmaceuticals and steel are experiencing reductions in foreign holdings [1][5][8]

本文源自：智通财经网 截至公告日，股东合计质押4,225万股，占所持股份34.21%，占公司总股本10.98%。 智通财经获悉，吉宏股份(02603)涨超3%，截至发稿，涨3.36%，报16.6港元，成交额1670.45万港元。 消息面上，7月28日，吉宏股份发布公告，控股股东庄浩解除质押360万股，占其所持股份5.17%，占公 司A股股本0.94%；庄澍质押470万股，占其所持股份13.56%，占公司A股股本1.22%。本次调整后，庄 浩剩余质押股份数量为2,635万股，占其所持股份37.85%，占总股本6.85%；庄澍质押后累计质押1,590 万股，占其所持股份45.86%，占总股本4.13%。 ...

Group 1 - The stock of Jihong Co., Ltd. (02603) increased by over 3%, specifically by 3.36%, reaching HKD 16.6, with a trading volume of HKD 16.7045 million [1] - On July 28, Jihong Co., Ltd. announced that its controlling shareholder, Zhuang Hao, released the pledge of 3.6 million shares, which accounts for 5.17% of his holdings and 0.94% of the company's A-share capital [1] - Zhuang Shu pledged 4.7 million shares, representing 13.56% of his holdings and 1.22% of the company's A-share capital [1] Group 2 - After the adjustments, Zhuang Hao has 26.35 million shares pledged, which is 37.85% of his holdings and 6.85% of the total share capital [1] - Zhuang Shu has cumulatively pledged 15.9 million shares, accounting for 45.86% of his holdings and 4.13% of the total share capital [1] - As of the announcement date, shareholders have a total of 42.25 million shares pledged, which is 34.21% of their holdings and 10.98% of the company's total share capital [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 XIAMEN JIHONG CO., LTD 廈門吉宏科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2603） （「本公司」） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而做出。 茲載列廈門吉宏科技股份有限公司於巨潮資訊網(www.cninfo.com.cn)刊登的公告 如下，僅供參閱。 承董事會命 廈門吉宏科技股份有限公司 執行董事兼總經理 莊浩女士 香港，2025年7月29日 於本公告日期，董事會成員包括(i)執行董事王亞朋先生、莊浩女士、張和平先生、 莊 澍 先 生 及 陸 它 山 先 生，(ii)非 執 行 董 事 廖 生 興 先 生，及(iii)獨立非執行董事 張國清博士、楊晨暉博士、薛永恒教授、韓建書先生及吳永蒨女士。 证券代码：002803 证券简称：吉宏股份 公告编号：2 ...

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index dropping over 1%, ending a five-day winning streak, closing at 25,388.35 points, down 1.09% or 278.83 points, with a total turnover of 281.77 billion HKD [1] - Despite the decline, the Hang Seng Index saw a weekly increase of 2.27%, while the Hang Seng China Enterprises Index and the Hang Seng Tech Index rose by 1.83% and 2.51% respectively [1] Blue Chip Performance - WuXi Biologics (02269) led the blue-chip stocks, rising 5.53% to 31.5 HKD, contributing 9.65 points to the Hang Seng Index, following a profit warning indicating a projected 16% revenue growth in the first half of 2025 [2] - Other notable blue-chip performances included SMIC (00981) up 4.98%, Nongfu Spring (09633) up 3.56%, while New Oriental (09901) and Shenzhou International (02313) saw declines of 3.36% and 2.94% respectively [2] Sector Highlights - Large tech stocks generally declined, with Alibaba down nearly 2% and Tencent over 1% [3] - Semiconductor stocks saw a rally, with Hua Hong Semiconductor rising 9% and SMIC up nearly 5% [3] - The pharmaceutical sector experienced gains, driven by a shift towards value assessment in drug procurement, with notable increases in stocks like Kanglong Chemical (03759) up 7.71% and Zhaoyan New Drug (06127) up 7.02% [4] - Airline stocks were active, with China Eastern Airlines (00670) up 3.69% and Air China (00753) up 3.68%, supported by strong summer travel demand [6][7] Regulatory Developments - The National Healthcare Security Administration announced changes to the 11th batch of centralized procurement, moving away from a simple lowest price reference, which is expected to curb vicious price competition and promote a shift towards value-based competition in the pharmaceutical industry [5] - The introduction of new policies aimed at supporting innovative drugs and medical devices was discussed in a recent meeting, indicating a focus on enhancing the clinical application of high-level technological innovations [5] Notable Stock Movements - Valiant Biopharma (09887) saw a significant increase of 91.71% on its debut, closing at 67.1 HKD, following a successful IPO [9] - Jihong Holdings (02603) rose 15.31% after announcing a projected net profit increase of 97.25% to 108.21% for the first half of 2025 [10] - COSCO Shipping Ports (01199) reached a new high, up 9.31%, amid reports of potential acquisitions of port assets [11] - Kintor Pharmaceutical (00148) announced a profit warning, leading to an 8.29% increase in stock price, with expected profits rising over 70% [12] - Lingbao Gold (03330) also saw gains, up 5.89%, with projected revenue growth of 75% to 85% for the first half of 2025 [13]

Group 1: Market Overview - The Hang Seng Index fell by 1.11%, down 284 points, closing at 25,383 points, while the Hang Seng Tech Index dropped by 1.69% [1] - The early trading volume in Hong Kong stocks reached 151 billion HKD [1] Group 2: Medical Sector - Medical device stocks rose in early trading, with the national drug procurement policy indicating a move away from internal competition, leading institutions to view this as a turning point for the industry [1] - Aikang Medical (01789) increased by 7.93%, and Weigao Group (01066) rose by 4.37% [1] - Yongsheng Medical (01612) saw a surge of over 27% following a profit warning, with sales orders increasing and expected mid-term net profit growth exceeding 50% year-on-year [2] - CRO concept stocks continued to rise, with Citigroup noting that the CXO sector is gaining market attention ahead of earnings season [2] - Kanglong Chemical (300759) (03759) rose by 8.4%, while Zhaoyan New Drug (603127) (06127) increased by 5.7%, and WuXi Biologics (02269) rose by 4.5% [2] Group 3: Consumer Sector - Nongfu Spring (09633) increased by over 3.56%, reaching a three-and-a-half-year high, with institutions expecting the company's first-half revenue growth to exceed market expectations [3] Group 4: Other Notable Stocks - Jihong Co., Ltd. (002803) (02603) rose by 16%, with two main business segments performing well, and expected first-half net profit growth of up to 65% [4] - China Merchants Port (01199) increased by over 4%, following reports that China Merchants Group plans to acquire assets from Cheung Kong Ports [5] - Guichuang Tongqiao (02190) rose by 2.6%, with expected mid-term net profit growth of 66.9%, as the company embraces procurement and actively expands overseas [6] Group 5: Lithium and Duty-Free Sector - News of supply disruptions in the lithium market led to Tianqi Lithium (002466) (09696) rising by 3.6% [7] - China Duty Free Group (601888) (01880) fell by over 6%, with pending details on Hainan's duty-free policies, and institutions noting that the closure operations have a dual impact on offshore duty-free business [7] Group 6: Technology Sector - Qianxun Technology (01640) fell by over 3%, having retreated 23% from its previous high, with recent comments from Yu Weiwen emphasizing the need to avoid excessive speculation on stablecoins [8]

表格類別： 股票 狀態： 新提交 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： 廈門吉宏科技股份有限公司 呈交日期： 2025年7月18日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 A | | 於香港聯交所上市 | 否 | | | 證券代號 (如上市) | 002803 | 說明 | 於深圳證券交易所上市之A股 | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前 ...